| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Research &Develop. | Chief Scientific Officer
1 company
Sethuraman Natarajan serves as a President, Research &Develop. at TRDA. Across recent SEC filings that breaks down to 0 buys and 21 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Sethuraman Natarajan's trades have earned a strong insider score of 83/100 across 20 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +51.1%.
The biggest single holding is TRDA (~$1.5M) as President, Research &Develop.. The recent filings there lean toward selling, a net 110,025 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell10b5-1 | 25,907 | $15.39 | $398,809.77 | -10.7% | -54.0% | - | |
| Dec 3, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell10b5-1 | 15,891 | $20.18 | $320,619.70 | -9.9% | -43.8% | -50.1% | |
| Nov 13, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell10b5-1 | 4,109 | $20.03 | $82,299.94 | -2.5% | -38.7% | -56.0% | |
| Nov 6, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell10b5-1 | 18,219 | $18.62 | $339,280.66 | -9.9% | -27.3% | -62.8% | |
| Oct 16, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell10b5-1 | 600 | $18.00 | $10,800.00 | -0.3% | -29.3% | -65.0% | |
| Sep 9, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 3,242 | $15.12 | $49,003.59 | -1.7% | +43.2% | -65.8% | |
| Jul 15, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 1,238 | $18.00 | $22,284.00 | -0.7% | -0.2% | -64.3% | |
| May 20, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 18,980 | $15.16 | $287,694.89 | -9.1% | +7.8% | -46.2% | |
| Jul 11, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 17,878 | $18.03 | $322,389.28 | -10.4% | -20.9% | -12.6% | |
| Apr 17, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 3,961 | $18.00 | $71,315.82 | -2.3% | -7.9% | -29.4% |